Skip to content

Russell Basser


Dr Russell Basser has been the Senior Vice President of Research and Development since the formation of Seqirus in 2015. Seqirus is one of the largest influenza vaccine companies in the world and a major partner in the prevention and control of influenza globally.

Dr Basser led the clinical and regulatory programs that led to licensure of CSL’s influenza vaccine globally (Fluvax in Australia, Afluria in the US, Enzira in Europe), Australian approval of the pre- pandemic H5N1 bird flu vaccine, as well as the 2009 H1N1 swine flu pandemic program.

Stay up to date with our upcoming events and special announcements by subscribing to the Wheeler Centre's mailing list.

Privacy Policy

The Wheeler Centre acknowledges the Wurundjeri Woi Wurrung people of the Kulin Nation as the Traditional Owners of the land on which the Centre stands. We acknowledge and pay our respects to all Aboriginal and Torres Strait Islander peoples and their Elders, past and present, as the custodians of the world’s oldest continuous living culture.